← All stocks

Aclaris Therapeutics, Inc.

ACRS Net selling
CIK 0001557746 #2604 in the set updated 17 Sep 2026
Bought (120 mo)
$14.84M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$82.89M
$136.02K on a plan · $2.91M straight out of an exercise
Sold at will
$79.84M
89 of 111 sales
Net
−$68.05M
−$65.00M against sales at will

By person

29 insiders · 162 transactions
11.3×

Neal Walker holds 11.3 times base salary in stock. $6.99M of shares against $615.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Neal Walker last reported holding, valued at $4.53, the price Common Stock was last bought or sold at on the open market here, on 23 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
VIVO VENTURES VII, LLC entity
10% owner
$34.01M (10)
−$34.01M
2,858,569
$12.95M
−31.8%
Mehra Anand
Director
$5.50M (2)
$21.19M (1)
−$15.69M
4,177,456
$18.92M
+9.1%
Flynn James E
10% owner
$7.74M (14)
−$7.74M
4,123,266
$18.68M
−30.0%
Walker Neal
CEO
$167.50K (1)
$5.37M (18)
−$5.20M
1,543,886
$6.99M
+77.1%
Leonard Braden Michael
10% owner
$5.59M (21)
$1.36M (1)
+$4.23M
13,950,000
$63.19M
+48.5%
Ali-Jackson Kamil
Chief Legal Officer
$3.20M (22) scheduled
−$3.20M
160,214
$725.77K
+110.9%
Ruffo Frank
Chief Financial Officer
$43.51K (2)
$2.85M (9)
−$2.81M
201,883
$914.53K
+41.5%
Monahan Joseph
Chief Scientific Officer
$2.14M (13)
−$2.14M
265,855
$1.20M
+363.8%
Gordon David N.
Chief Medical Officer
$1.19M (5)
−$1.19M
147,447
$667.93K
SCHIFF ANDREW N
Director
$2.50M (1)
$3.65M (12)
−$1.15M
1,094,450
$4.96M
−5.7%
Tullman Stephen A.
Director
$739.79K (4)
+$739.79K
571,471
$2.59M
−6.3%
Manion Douglas J.
Pres and CEO
$99.81K (2)
+$99.81K
41,813
$189.41K
FMR LLC entity
See Remark 1
$82.26K (2)
−$82.26K
4,506,831
$20.42M
−13.9%
Balthaser Kevin
Chief Financial Officer
$74.97K (1)
$23.58K (2) scheduled
+$51.39K
187,453
$849.16K
+26,679%
Loerop James
Chief Business Officer
$99.96K (1)
$59.27K (1)
+$40.69K
192,260
$870.94K
+402.5%
Molineaux Christopher P.
Director
$38.00K (1)
−$38.00K
69,536
$315.00K
Powell Andrew Kenneth William
Director
$27.52K (3)
+$27.52K
33,523
$151.86K
Powala Christopher
Chief Reg & Develop Officer
272,163
$1.23M
+4.3%
Shanler Stuart
Chief Scientific Officer
272,047
$1.23M
+4.3%
Davis Hugh M.
President and COO
45,425
$205.78K
Humphries William D.
Director
45,105
$204.33K
GOWEN MAXINE
Director
33,334
$151.00K
MILANO VINCENT
Director
28,896
$130.90K
Reasons Bryan M.
Director
28,732
$130.16K
Hall Jesse Wayne
Chief Medical Officer
27,045
$122.51K
Kolbeck Roland Wilhelm
Chief Scientific Officer
23,990
$108.67K
Fair Brett
Chief Commercial Officer
10,582
$47.94K
+236.9%
Cawkwell Gail
Chief Medical Officer
9,593
$43.46K
Foresite Capital Management III, LLC entity
10% owner
8,276
$37.49K
−99.6%

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 71,430,942 to 147,198,893 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Walker Neal
4 Dec 2024
INTERIM CEO
Exercised, kept
118,840
$1.52
$180.64K
Walker Neal
9 Aug 2024
INTERIM PRESIDENT AND CEO
Exercised, kept
43,548
$0.72
$31.35K
Molineaux Christopher P.
20 Jun 2023
Director
Exercised, kept
16,500
$1.41
$23.27K
Molineaux Christopher P.
15 Jun 2023
Director
Exercised, kept
198
$1.52
$300.96
Molineaux Christopher P.
15 Jun 2023
Director
Exercised, kept
51
$0.72
$36.72
Mehra Anand
2 Feb 2021
Director
Exercised, kept
6,632
$18.32
$121.50K
Mehra Anand
2 Feb 2021
Director
Exercised, kept
8,000
$18.35
$146.80K
Molineaux Christopher P.
20 Mar 2018
Director
Exercised, kept
264
$1.52
$401.28
Molineaux Christopher P.
20 Mar 2018
Director
Exercised, kept
120
$0.72
$86.40
Molineaux Christopher P.
20 Mar 2018
Director
Exercised, kept
1,993
$0.41
$817.13
Molineaux Christopher P.
17 Mar 2017
Director
Exercised, kept
311
$0.72
$223.92
Molineaux Christopher P.
17 Mar 2017
Director
Exercised, kept
592
$1.52
$899.84
Molineaux Christopher P.
17 Mar 2017
Director
Exercised, kept
6,702
$0.41
$2.75K

What was left out

Form 4 filings counted 343
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 19
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 7,189,262
Sales filed before the plan box existed 88
History held since 31 Aug 2016